Astellas Pharma Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALPMY Over the counter 2830 www.astellas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Astellas Pharma Inc.

Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines - Dec 11th, 2025 5:30 am
Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium - Dec 10th, 2025 4:30 pm
Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting - Dec 5th, 2025 6:00 am
Should FDA Approval of PADCEV-Keytruda Combo Shape the Outlook for Pfizer (PFE) Investors? - Nov 25th, 2025 1:11 am
Astellas Pharma (TSE:4503): Exploring Valuation After Strong 21% Monthly Share Price Rally - Nov 22nd, 2025 5:12 am
Sector Update: Health Care Stocks Higher Late Afternoon - Nov 21st, 2025 1:45 pm
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer - Nov 21st, 2025 11:24 am
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3? - Nov 21st, 2025 8:30 am
Renal Anemia Market Research Report 2025-2035, Competitive Analysis of Amgen, Sandoz, Pfizer, GlaxoSmithKline, Akebia Therapeutics, and Astellas Pharma - Nov 18th, 2025 8:37 am
Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson - Oct 30th, 2025 11:16 am
Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study - Oct 26th, 2025 5:25 am
How Recent Clinical and Regulatory Advances at Astellas Pharma (TSE:4503) Have Changed Its Investment Story - Oct 23rd, 2025 10:15 am
Astellas and the Internet's Favorite Grandma, Barbara 'Babs' Costello, Partner to Encourage Others to Get Ahead of Geographic Atrophy (GA) - Oct 23rd, 2025 6:00 am
United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - Oct 23rd, 2025 3:38 am
Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study - Oct 22nd, 2025 6:00 am
PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer - Oct 21st, 2025 5:30 pm
Pfizer, Astellas Pharma Say Drug Combination Reduces Risk of Prostate Cancer Death - Oct 20th, 2025 2:38 am
IZERVAY™ (avacincaptad pegol intravitreal solution) Showed Increased Benefit in Reducing Geographic Atrophy Progression Over Time and Consistent Long-Term Safety - Oct 19th, 2025 5:30 pm
What Pfizer (PFE)'s Phase 3 Oncology Advances Mean for Shareholders - Oct 18th, 2025 10:12 am
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients - Oct 18th, 2025 8:30 am